Evidence map›Paper›PMID 27175011›Full record

ArticleMolecular pain2016

Spinal astrocytic activation contributes to both induction and maintenance of pituitary adenylate cyclase-activating polypeptide type 1 receptor-induced long-lasting mechanical allodynia in mice.

Masafumi Yokai, Takashi Kurihara, Atsuro Miyata

Open access · goldAbstract read
In one paragraph

Article in Molecular pain, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.7field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Review
  3. Optogenetic and Chemogenic Control of Pain Signaling: Molecular Markers.International journal of molecular sciences · 2023
    Review
  4. Article
  5. Article
  6. A Female-Specific Role for Calcitonin Gene-Related Peptide (CGRP) in Rodent Pain Models.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2022
    Article
  7. Protective Effects of PACAP in a Rat Model of Diabetic Neuropathy.International journal of molecular sciences · 2021
    Article
  8. Novel Analgesics with Peripheral Targets.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2020
    Review
  9. Article
  10. The Astrocytic cAMP Pathway in Health and Disease.International journal of molecular sciences · 2019
    Review
  11. Article
  12. Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Masafumi YokaiDepartment of Pharmacology, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima City, Japan.
Takashi KuriharaDepartment of Pharmacology, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima City, Japan tkmphm10@m.kufm.kagoshima-u.ac.jp.
Atsuro MiyataDepartment of Pharmacology, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima City, Japan.
Kagoshima University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPituitary adenylate cyclase-activating polypeptide (PACAP) and its receptors are present in the spinal dorsal horn and dorsal root ganglia, suggesting an important role of PACAP-PACAP receptors signaling system in the modulation of spinal nociceptive transmission. We have previously reported that a single intrathecal injection of PACAP or a PACAP specific (PAC1) receptor selective agonist, maxadilan, in mice induced dose-dependent aversive behaviors, which lasted more than 30 min, and suggested that the maintenance of the nociceptive behaviors was associated with the spinal astrocytic activation.

resultsWe found that a single intrathecal administration of PACAP or maxadilan also produced long-lasting hind paw mechanical allodynia, which persisted at least 84 days without affecting thermal nociceptive threshold. In contrast, intrathecal application of vasoactive intestinal polypeptide did not change mechanical threshold, and substance P, calcitonin gene-related peptide, or N-methyl-D-aspartate induced only transient mechanical allodynia, which disappeared within 21 days. Western blot and immunohistochemical analyses with an astrocytic marker, glial fibrillary acidic protein, revealed that the spinal PAC1 receptor stimulation caused sustained astrocytic activation, which also lasted more than 84 days. Intrathecal co-administration of L-α-aminoadipate, an astroglial toxin, with PACAP or maxadilan almost completely prevented the induction of the mechanical allodynia. Furthermore, intrathecal treatment of L-α-aminoadipate at 84 days after the PAC1 stimulation transiently reversed the mechanical allodynia accompanied by the reduction of glial fibrillary acidic protein expression level.

conclusionOur data suggest that spinal astrocytic activation triggered by the PAC1 receptor stimulation contributes to both induction and maintenance of the long-term mechanical allodynia.

Indexed as

AdipatesAnimalsAstrocytesEnzyme ActivationExtracellular Signal-Regulated MAP KinasesFluorescent Antibody TechniqueGlial Fibrillary Acidic ProteinHyperalgesiaInjections, SpinalInsect ProteinsJNK Mitogen-Activated Protein KinasesMaleMicePituitary Adenylate Cyclase-Activating PolypeptideProtein Kinase InhibitorsReceptors, Pituitary Adenylate Cyclase-Activating Polypeptide, Type IAdipatesadipic acidExtracellular Signal-Regulated MAP KinasesGlial Fibrillary Acidic ProteinInsect ProteinsJNK Mitogen-Activated Protein Kinasesmaxadilan protein, insectPituitary Adenylate Cyclase-Activating PolypeptideProtein Kinase InhibitorsReceptors, Pituitary Adenylate Cyclase-Activating Polypeptide, Type Ic-Jun-N-terminal kinaseERKextracellular signal-regulated kinaseGFAPglial fibrillary acidic proteinJNKMAP kinasePAC1 receptorPACAP

Identifiers

PMID27175011
PMCPMC4956379
OpenAlexW2390471577

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.